M4MM

SNDL Reports Q4 and FY 2025 Financial Results

EDMONTON – SNDL Inc. disclosed its fourth-quarter and full-year 2025 earnings for the period ended December 31, 2025, illustrating a clear divergence in performance across its two main retail pillars: sustained progress and margin expansion ...

Ascend Wellness Reports Q4 and FY 2025 Financial Results

NEW YORK – Ascend Wellness Holdings Inc. released its fourth-quarter and full-year 2025 earnings, underscoring a calculated shift among MSOs toward operational and margin discipline in response to persistent industry challenges. The disclosure illustrates how ...

Organigram Reports Q1 Fiscal 2026 Financial Results

TORONTO – Organigram Global Inc. delivered a notable performance in its first quarter of fiscal 2026, posting substantial revenue increases and a return to profitability as the Canadian Cannabis producer continues to integrate recent acquisitions ...

SNDL Reports Q4 and FY 2025 Financial Results

EDMONTON – SNDL Inc. disclosed its fourth-quarter and full-year 2025 earnings for the period ended December 31, 2025, illustrating a clear divergence in performance across its two main retail pillars: sustained progress and margin expansion ...

Ascend Wellness Reports Q4 and FY 2025 Financial Results

NEW YORK – Ascend Wellness Holdings Inc. released its fourth-quarter and full-year 2025 earnings, underscoring a calculated shift among MSOs toward operational and margin discipline in response to persistent industry challenges. The disclosure illustrates how ...

Global Developments in Cannabis Legalization in 2023

LOS ANGELES- In 2023, several countries made significant strides in cannabis legalization, reflecting a global shift in drug policy. Germany's Legislative Progress Germany advanced toward legalizing cannabis for adult use, aiming to become the European ...

Michigan Transfers Hemp Regulation to USDA

LOS ANGELES- Michigan has concluded its state-managed industrial hemp program, transitioning regulatory oversight to the U.S. Department of Agriculture (USDA) effective January 1, 2025. This shift, prompted by the enactment of House Bill 5977, dissolves ...

DEA Postpones Cannabis Rescheduling Hearings to 2025

LOS ANGELES-The U.S. Drug Enforcement Administration (DEA) has postponed its hearings on the proposed rescheduling of cannabis under the Controlled Substances Act (CSA) to early 2025. The delay follows a preliminary order from Chief Administrative ...

Subscribe To Our Newsletter